Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- More Strict with Hospitals in Illegal Cases: New Medical Service Law
March 12, 2001
- OTC NEWS IN BRIEF
March 12, 2001
- Nicorette Reexamined, 2 New Orphan Drugs Designated
March 12, 2001
- Sankyo Aims at \1 Trillion Sales in FY2010: President Takato
March 12, 2001
- Q&A Booklet on New PMS for 6 Months after Launching Issued
March 12, 2001
- MTP Ties Up with Sumitomo, MedGene Regarding HGF
March 12, 2001
- REGULATORY NEWS IN BRIEF
March 12, 2001
- Hokuriku: Hokunalin Tape, Ganaton Boost Sales, Operating Profits
March 12, 2001
- Taisho Signs Anti-Asthma Drug License Agreement with EpiGenesis
March 12, 2001
- JMARI to Conduct Survey to Propose New Medical Fee Payment Method
March 12, 2001
- Roche CEO Expects Leadership from Mr Ogawa
March 5, 2001
- Nippon Shinyaku to Terminate Development of NS-49
March 5, 2001
- JPMA Compiles Report on Globalization
March 5, 2001
- Nippon Shinyaku, SSP to Codevelop Synthetic Steroid
March 5, 2001
- Drug Wholesaler Tie-ups, M&As in 2000
March 5, 2001
- Only 70% of Hospitals Hire No. of Drs Required by Law
March 5, 2001
- SAS Institute to Start New Portal Service for R&D
March 5, 2001
- COX2 Inhibitor Expected to Prevent NSAID-induced Ulcers: Pharmacia Forum
March 5, 2001
- AstraZeneca to Launch 3 New Drugs per Year in All Major Markets
March 5, 2001
- Large Intervention Study on Hypertension Targets 9,000 Patients in Japan
March 5, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…